1%

Question 1 of 60

Hepatitis B vaccines:

Rationale:
Hepatitis B vaccines are very effective if used for post-exposure prophylaxis. This effectiveness arises from the vaccine's ability to stimulate a robust immune response, reducing the likelihood of infection after potential exposure to the virus. A: Are not effective in patients with acute hepatitis B. Acute hepatitis B is a transient phase, and the vaccine's role is preventative rather than treatment-focused during this time. B: Are live attenuated vaccines. Hepatitis B vaccines consist of recombinant proteins, not live attenuated viruses, ensuring safety for immunocompromised individuals and preventing potential infections. C: Fewer than 10% of adults fail to respond to hep B vaccines adequately. While vaccine responsiveness can vary, a significant percentage of adults do respond well, and this figure may not reflect all populations.